Oral Lichen Planus: An Updated Review of Etiopathogenesis, Clinical Presentation, and Management
- PMID: 38283029
- PMCID: PMC10810384
- DOI: 10.4103/idoj.idoj_652_22
Oral Lichen Planus: An Updated Review of Etiopathogenesis, Clinical Presentation, and Management
Abstract
Lichen planus (LP) is a chronic idiopathic immune-mediated inflammatory condition. LP is a heterogeneous disease with varied clinical presentations having different natural history, prognosis, sequelae, and outcomes. It can affect skin, hair, nails, and mucosae. Mucosal LP (including oral LP) tends to be persistent and resistant to treatment, compared to cutaneous LP. Oral LP (OLP) is broadly divided into two main categories: hyperkeratotic (usually asymptomatic) and erosive (commonly symptomatic). It can present with symptoms including odynophagia, dysphagia, dysgeusia, and sensitivity to hot spicy foods. Apart from the superficial epidermal changes, which vary with the type of clinical presentation, histopathologically oral LP shows a unifying similar and consistent feature of a lichenoid interface dermatitis. Recently, researchers have highlighted the critical role played by IL-17 in the pathogenesis of OLP. World Health Organization has categorized oral LP as one of the oral potentially malignant disorders (OPMD), albeit with a low risk of malignant transformation. Also, in the last couple of years there have been various reports on the usage of newer drugs like anti-IL17, anti-IL12/23, anti-IL 23, PDE4 inhibitors, and JAK inhibitors in the management of refractory OLP. The principal aim of treatment still remains to resolve the symptoms, prolong the symptoms free period, and reduce the risk of potential malignant transformation. We have described many new revelations made in recent times regarding the etiopathogenesis, associated conditions as well as management of OLP. Thus, the objective of this review is to present a comprehensive up-to-date knowledge including the recent advances made regarding OLP.
Keywords: New pathogenesis; Oral lichen planus; patterns.
Copyright: © 2023 Indian Dermatology Online Journal.
Conflict of interest statement
There are no conflicts of interest.
Figures






References
-
- Tziotzios C, Lee JYW, Brier T, Saito R, Hsu CK, Bhargava K, et al. Lichen planus and lichenoid dermatoses: Clinical overview and molecular basis. J Am Acad Dermatol. 2018;79:789–804. - PubMed
-
- Di Stasio D, Guida A, Salerno C, Contaldo M, Esposito V, Laino L, et al. Oral lichen planus: A narrative review. Front Biosci (Elite Ed) 2014;6:370–6. - PubMed
-
- Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575–80. - PubMed
-
- Yamanaka Y, Yamashita M, Innocentini LMA, Macedo LD, Chahud F, Ribeiro-Silva A, et al. Direct immunofluorescence as a helpful tool for the differential diagnosis of oral lichen planus and oral lichenoid lesi ons. Am J Dermatopathol. 2018;40:491–97. - PubMed
Publication types
LinkOut - more resources
Full Text Sources